Desogestrel ethinyl estradiol (DES) is a revolutionary hormonal contraceptive that has been used since the 1960s. It is a combination of two hormones, desogestrel and ethinyl estradiol, which work together to prevent pregnancy. DES is one of the most effective forms of contraception and is used by millions of women around the world. In this article, we will take a comprehensive look at the benefits of DES and how it can help women prevent pregnancy.
DES is a combination of two hormones, desogestrel and ethinyl estradiol, which work together to prevent pregnancy. When taken orally, DES works by preventing ovulation, which means that a woman's body does not release an egg that could potentially be fertilized by sperm. This process is known as ovulation inhibition. In addition, DES thickens the mucus in the cervix, which makes it harder for sperm to reach the uterus and fertilize an egg.
There are a number of benefits to using DES as a method of contraception. First, it is highly effective in preventing pregnancy. Studies have shown that DES is more than 99% effective when taken correctly and consistently. This makes it one of the most reliable forms of contraception available. In addition, DES is convenient and easy to use. It is available in pill form, which means that it can be taken at the same time each day. This makes it easy to remember and reduces the risk of forgetting to take the pill. Finally, DES is a safe and reliable form of contraception. It is a low-dose hormonal contraceptive, which means that it does not have the same side effects as other forms of contraception. Studies have shown that DES is safe to use for long periods of time and does not increase the risk of developing certain health conditions.
While DES is a safe and reliable form of contraception, there are some risks associated with its use. The most common side effects of DES are nausea, breast tenderness, headaches, and irregular bleeding. These side effects are usually mild and do not last long. In addition, DES can increase the risk of developing certain health conditions, such as blood clots, stroke, and heart attack. Women who are at an increased risk of developing these conditions should speak to their doctor before taking DES.
Desogestrel ethinyl estradiol (DES) is a revolutionary hormonal contraceptive that has been used since the 1960s. It is a combination of two hormones, desogestrel and ethinyl estradiol, which work together to prevent pregnancy. DES is one of the most effective forms of contraception and is used by millions of women around the world. It is highly effective in preventing pregnancy, is convenient and easy to use, and is a safe and reliable form of contraception. However, there are some risks associated with its use, such as nausea, breast tenderness, headaches, and irregular bleeding. Women who are at an increased risk of developing certain health conditions should speak to their doctor before taking DES.
1.
MRI can save rectal cancer patients from surgery, study suggests
2.
When Healthcare Chatbots Fall Short of Human Connection
3.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
4.
Antibiotic Use in Hospice Linked to Higher Mortality Risk
5.
Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status
1.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
2.
Genetic Screening: A Game Changer in Cancer Prevention
3.
All You Need to Know About Mesna: The Ultimate Guide
4.
Unveiling the Hidden Causes of Anemia: A Comprehensive Look at a Common Condition
5.
Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Innovations in Hematology
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
3.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Blood Clotting Disorders Explained
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation